Cyclic antibiotic therapy for diverticular disease: a critical reappraisal

Cesare Hassan, A Zullo, G Maconi, G Manes, G Tammaro, V De Francesco, B Annibale, L Ficano, L Buri, G Gatto, R Lorenzetti, Sm Campo, E Ierardi, F Pace, S. Morini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

25 Citazioni (Scopus)

Abstract

Different symptoms have been attributed to uncomplicated diverticular disease (DD). Poor absorbable antibiotics are largely used for uncomplicated DD, mainly for symptom treatment and prevention of diverticulitis onset. Controlled trials on cyclic administration of rifaximin in DD patients were evaluated. Four controlled, including 1 double-blind and 3 open-label, randomized studies were available. Following a long-term cyclic therapy, a significant difference emerged in the global symptoms score (range: 0-18) between rifaximin plus fibers (from 6-6.5 to 1-2) and fibers alone (from 6.7 to 2-3.8), although the actual clinically relevance of such a very small difference remains to be ascertained. Moreover, a similar global symptom score reduction (from 6 to 2.4) can be achieved by simply recommending an inexpensive high-fiber diet. Current data suggest that cyclic rifaximin plus fibers significantly reduce the incidence of the first episode of acute diverticulitis as compared to fibers alone (1.03% vs 2.75%), but a cost-efficacy analysis is needed before this treatment can be routinely recommended. The available studies have been hampered by some limitations, and definite conclusions could not be drawn. The cost of a long-life, cyclic rifaximin therapy administered to all symptomatic DD patients would appear prohibitive.
Lingua originaleEnglish
pagine (da-a)295-302
Numero di pagine8
RivistaJOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
Volume19
Stato di pubblicazionePubblicato - 2010
Pubblicato esternamente

Keywords

  • Anti-Bacterial Agents
  • Dietary Fiber
  • Diverticulitis
  • Diverticulum
  • Drug Administration Schedule
  • Evidence-Based Medicine
  • Humans
  • Patient Selection
  • Rifamycins
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Cyclic antibiotic therapy for diverticular disease: a critical reappraisal'. Insieme formano una fingerprint unica.

Cita questo